According to SPER Market Research, the Western Blotting Market to reach USD 1.6 billion by 2030 with a CAGR of 5.9%. The prevalence of HIV/AIDS worldwide, increase funding in biomedical sector, and shift towards personalized medicine and innovative technologies; these are the fuel for growth of this market.
Western blotting is an analytical technique to detect, analyze, and quantify proteins. It can detect picogram levels of protein in a sample.
The COVID-19, gives a boost to the research and development, thereby landing opportunities for companies to make profit.
The continual use of consumables & reagents in huge amounts in the western blotting are the cause of highest share of product segment in this market.
Due to increase in proteomic research and government funding the academic & research institutes shares the largest share in this market.
Western blotting is used for medical diagnosis of infectious diseases like Lyme disease, HIV infection, bovine spongiform encephalopathy (BSE), hepatitis C infection, syphilis, inflammatory muscle conditions, and certain autoimmune disorders.
The invention of upgraded, advanced, cost-effective alternative techniques, high cost, highly efficient, precise methodology, analytical methods to get reliable data, failure and data variation rates are high in western blotting; these are some challenges associated with this market growth.
There will be huge opportunities in the Asia Pacific, Latin America, the Middle East & Africa, due to increasing the innovation in the research & development, health care market, personalized medicine, developments in research infrastructure and the economical manufacturing cost of emerging APAC countries encourage market players to invest in this market.
North America dominates the highest share of this market, is due to the presence of big companies, increase in investment in biomedical research, and demand for personalized medicine.
The global western blotting market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as; Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Danaher Corporation, Merck KGaA, Thermo Fisher Scientific.
SPER Market Research study aims to provide market dynamics, demand and supply with yearly forecast to 2030. This report provides data for growth estimates and forecasts for Product segments- Consumables (Reagents & Buffers, Antibodies & Conjugates, Kits, Membranes & Filter Papers, Other Consumables), Instruments {Electrophoresis Instruments, Blotting Systems, Imagers (Chemiluminescent Imagers, Fluorescent Imagers, Other Imagers)}, End Users segment- Academic & Research Institutes, Biopharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Other End Users.
This report also provides the data for key regional segments of North America, Europe, Asia-Pacific and Rest of the World.
This study also encompasses various drivers and restraining factors for this market for the forecast period. Various growth opportunities are also discussed in the report.